REGENXBIO INC. 2024-2025 Proxy Voting Records

Description as filed by funds: Election of Four Class I Directors: Allan M. Fox

REGENXBIO INC.’s own tally for this item (“Elect Director: Allan Fox”): 27,990,560 for, 6,436,985 withheld, per its Form 8-K filed June 3, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1 : By the following vote, the following four persons were elected to serve as Class I directors until the Company's 2028 annual meeting of stockholders:”
Support: 81% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 44 asset managers below reported 10,394,785 for, 1,182,826 withheld, 34,620 abstained.

Showing the 25 largest of 44 asset managers. See all 44 in the interactive database.

Description as filed by funds: Election of Four Class I Directors: Curran Simpson

REGENXBIO INC.’s own tally for this item (“Elect Director: Curran Simpson”): 32,802,148 for, 1,625,397 withheld, per its Form 8-K filed June 3, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1 : By the following vote, the following four persons were elected to serve as Class I directors until the Company's 2028 annual meeting of stockholders:”
Support: 95% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 44 asset managers below reported 10,791,421 for, 803,534 withheld, 17,276 abstained.

Showing the 25 largest of 44 asset managers. See all 44 in the interactive database.

Description as filed by funds: Election of Four Class I Directors: Jennifer Zachary

REGENXBIO INC.’s own tally for this item (“Elect Director: Jennifer Zachary”): 29,179,798 for, 5,247,747 withheld, per its Form 8-K filed June 3, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1 : By the following vote, the following four persons were elected to serve as Class I directors until the Company's 2028 annual meeting of stockholders:”
Support: 85% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 44 asset managers below reported 10,527,782 for, 1,049,829 withheld, 34,620 abstained.

Showing the 25 largest of 44 asset managers. See all 44 in the interactive database.

Description as filed by funds: Election of Four Class I Directors: Alexandra Glucksmann, Ph.D.

REGENXBIO INC.’s own tally for this item (“Elect Director: Alexandra Glucksmann, Ph.D.”): 29,264,825 for, 5,162,720 withheld, per its Form 8-K filed June 3, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1 : By the following vote, the following four persons were elected to serve as Class I directors until the Company's 2028 annual meeting of stockholders:”
Support: 85% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 35 asset managers below reported 5,461,673 for, 1,049,829 withheld.

Showing the 25 largest of 35 asset managers. See all 35 in the interactive database.

Description as filed by funds: To approve the REGENXBIO Inc. 2025 Equity Incentive Plan.

REGENXBIO INC.’s own tally for this item (“5. The REGENXBIO Inc”): 27,395,802 for, 6,974,246 against — passed, per its Form 8-K filed June 3, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 5 : By the following vote, the stockholders approved, the REGENXBIO Inc. 2025 Equity Incentive Plan:”
Support: 80% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 44 asset managers below reported 9,929,092 for, 1,683,139 against.

Showing the 25 largest of 44 asset managers. See all 44 in the interactive database.

Description as filed by funds: Advisory vote on the compensation paid to the Company's named executive officers.

REGENXBIO INC.’s own tally for this item (“3. The compensation of the Company's named executive officers, as disclosed in the Proxy Statement”): 32,577,603 for, 1,756,155 against — passed, per its Form 8-K filed June 3, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 3 : By the following vote, the stockholders approved, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement:”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 44 managers: 11,460,547 for, 132,241 against, 19,443 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 131 managers: 18,616,963 for, 376,744 against, 250 abstained, 15,039 1 year. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: Advisory vote on the frequency of future stockholder advisory votes on the compensation paid to the Company's named executive officers.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports, all 44 managers: 19,443 abstained, 10,940,421 1 year, 652,367 3 year. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 124 managers: 997,413 for, 320 against, 250 abstained, 13,851,706 1 year, 132,082 3 year. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: To ratify the appointment of PricewaterhouseCoopers LLP by the Audit Committee of the Board of Directors as the Company's independent registered public accounting firm for the year ending December 31, 2025.

REGENXBIO INC.’s own tally for this item (“2. The appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025”): 41,172,522 for, 39,375 against — passed, per its Form 8-K filed June 3, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 2 : By the following vote, the stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025:”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 44 asset managers below reported 11,592,787 for, 1 against, 19,443 abstained.

Showing the 25 largest of 44 asset managers. See all 44 in the interactive database.